— Know what they know.
Not Investment Advice

FDMT NASDAQ

4D Molecular Therapeutics, Inc.
1W: -11.4% 1M: -11.3% 3M: -3.7% YTD: +18.7% 1Y: +125.7% 3Y: -51.4% 5Y: -67.2%
$8.60
-0.09 (-1.04%)
 
Weekly Expected Move ±9.2%
$7 $8 $9 $10 $11
NASDAQ · Healthcare · Biotechnology · Alpha Radar Sell · Power 32 · $449.6M mcap · 39M float · 1.91% daily turnover · Short 63% of daily vol

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

WEAK EDGE
45.9 / 100
NoneWeakNarrowWide
Primary source: Network Effects  ·  ROIC: -114.0%  ·  5Y Avg: 4.9%
Cost Advantage
38
Intangibles
48
Switching Cost
57
Network Effect
58
Scale
22
The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. FDMT shows a Weak competitive edge (45.9/100) — limited structural advantages that may face competitive pressure. The primary source of advantage is Network Effects. Negative ROIC of -114.0% indicates the company is currently destroying value, though this may reflect a growth investment phase.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets
$33
Low
$33
Avg Target
$33
High
Based on 1 analyst since May 7, 2026 earnings
Analyst Recommendations
Strong Buy: 0Buy: 10Hold: 3Sell: 1Strong Sell: 0
Rating Summary
ConsensusBuy
Avg Target$33.00
Analysts1
Price Target Change History
DateFirmAnalystOldNewChangeUpside @ CallStock@Call
2026-05-08 Goldman Sachs Initiated $33 +232.3% $9.93
2025-11-11 Barclays Gena Wang $45 $33 -12 +224.5% $10.17
2025-10-31 Leerink Partners Mani Foroohar Initiated $17 +47.8% $11.50
2025-10-21 RBC Capital Lisa Walter $40 $26 -14 +141.5% $10.77
2025-01-11 Morgan Stanley Judah Frommer Initiated $6 +8.7% $5.52
2024-09-19 BMO Capital Kostas Biliouris $63 $40 -23 +201.2% $13.28
2024-09-19 Loop Capital Markets Geulah Livshits Initiated $39 +193.0% $13.31
2024-09-19 H.C. Wainwright Matthew Caufield $36 $36 0 +170.4% $13.31
2024-04-15 RBC Capital Lisa Walter Initiated $40 +51.8% $26.35
2024-04-14 Barclays Gena Wang Initiated $45 +70.8% $26.35
2024-04-01 Jefferies Nalin Tejavibulya Initiated $58 +82.0% $31.86
2024-03-28 BMO Capital Kostas Biliouris $70 $63 -7 +99.4% $31.59
2024-02-06 BMO Capital Kostas Biliouris Initiated $70 +128.0% $30.70
2023-07-05 Chardan Capital Geulah Livshits Initiated $30 +62.8% $18.43
2022-11-18 H.C. Wainwright Initiated $36 +60.7% $22.40
2022-04-04 Evercore ISI Josh Schimmer Initiated $40 +172.9% $14.66

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

C+
May 22, 2026
DCF
3
ROE
1
ROA
1
D/E
3
P/E
1
P/B
4
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. FDMT receives an overall rating of C+. Strongest factors: P/B (4/5). Areas of concern: ROE (1/5), ROA (1/5), P/E (1/5).
Rating Change History
DateFromTo
2026-04-30 C C+
2026-04-28 C+ C
2026-04-01 B- C+
2026-03-24 C+ B-
2026-03-19 C C+
2026-03-18 C+ C

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

48 Grade D
Profitability
10
Balance Sheet
84
Earnings Quality
71
Growth
76
Value
49
Momentum
70
Safety
100
Cash Flow
30
The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. FDMT scores highest in Safety (100/100) and lowest in Profitability (10/100). A grade of D flags significant fundamental concerns across multiple dimensions.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
4.35
Safe Zone
Piotroski F-Score
4/9
Beneish M-Score
191.94
Possible Manipulator
Ohlson O-Score
-4.98
Bankruptcy prob: 0.7%
Low Risk
Credit Rating
A+
Score: 75.6/100
Trend: Improving
Earnings Quality
OCF/NI: 0.80x
Accruals: -5.6%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. FDMT scores 4.35, placing it in the Safe Zone (safe > 2.99, distress < 1.81). Bankruptcy is statistically unlikely within the next two years. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. FDMT scores 4/9, indicating moderate financial health — some areas of strength offset by weaknesses in others. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. FDMT's score of 191.94 exceeds the −1.78 red flag threshold — this does not confirm manipulation but indicates the earnings profile resembles past manipulators statistically. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. FDMT's implied 0.7% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. FDMT receives an estimated rating of A+ (score: 75.6/100), with a improving trend.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
-3.64x
PEG
-0.83x
P/S
5.09x
P/B
1.30x
P/FCF
-4.87x
P/OCF
EV/EBITDA
-1.41x
EV/Revenue
2.86x
EV/EBIT
-1.41x
EV/FCF
-1.94x
Earnings Yield
-25.39%
FCF Yield
-20.52%
Shareholder Yield
0.00%
Graham Number
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. FDMT currently has negative earnings — the P/E ratio is not meaningful.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
1.000
NI / EBT
×
Interest Burden
0.896
EBT / EBIT
×
EBIT Margin
-2.035
EBIT / Rev
×
Asset Turnover
0.157
Rev / Assets
×
Equity Multiplier
1.109
Assets / Equity
=
ROE
-31.7%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. FDMT's ROE of -31.7% is driven by Asset Turnover (0.157), indicating efficient use of assets to generate revenue. A tax burden ratio of 1.00 indicates minimal tax leakage — the company retains over 90% of pre-tax earnings.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Adj. Growth Rate
0.00%
Fair P/E
8.50x
Intrinsic Value
Price/Value
Margin of Safety
Premium
Assessment
Overvalued

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1367 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$8.60
Median 1Y
$4.44
5th Pctile
$1.06
95th Pctile
$18.64
Ann. Volatility
87.3%
Analyst Target
$33.00
25th–75th percentile 5th–95th percentile Median path Historical Analyst target

Executive Compensation

C-suite compensation breakdown including salary, stock awards, options, and incentive pay. The CEO-to-employee pay ratio and Gini coefficient measure pay distribution fairness.

C-Suite Compensation

ExecutiveSalaryStockTotal
Kristian Humer Financial
ancial Officer
$66,000 $— $3,990,903
David Kirn, M.D.
President and Chief Executive Officer
$667,252 $— $2,051,343
Fariborz Kamal, Ph.D.
Former Chief Operating Officer & President
$551,743 $— $1,441,573

CEO Pay Ratio

1672:1
CEO-to-Employee Pay Ratio
CEO Total Comp: $2,051,343
Avg Employee Cost (SGA/emp): $1,227
Employees: 40,000

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees
40,000
+17521.2% YoY
Revenue / Employee
$2,130
Rev: $85,209,000
Profit / Employee
$-3,503
NI: $-140,109,000
SGA / Employee
$1,227
Avg labor cost proxy
R&D / Employee
$4,892
Innovation spend

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
ROE -17.4% -26.0% -24.8% -28.2% -35.4% -36.6% -39.1% -39.9% -40.5% -34.9% -37.4% -38.8% -40.8% -53.2% -39.3% -43.1% -47.9% -51.1% -27.6% -31.7% -31.66%
ROA -15.4% -23.2% -22.2% -25.3% -31.7% -32.8% -34.9% -35.7% -36.2% -31.2% -33.5% -34.8% -36.5% -47.7% -35.7% -39.2% -43.6% -46.5% -24.9% -28.6% -28.55%
ROIC 1.7% 2.6% -64.2% -73.3% -92.0% -95.5% -2.6% -2.7% -2.7% -2.4% -2.6% -2.8% -3.0% -3.9% -1.3% -1.5% -1.6% -1.6% -1.0% -1.1% -1.14%
ROCE -16.3% -24.7% -21.2% -24.1% -30.3% -31.5% -44.7% -46.2% -47.7% -42.6% -35.2% -37.7% -40.9% -52.5% -35.4% -38.3% -41.5% -42.6% -30.5% -34.3% -34.35%
Gross Margin -4.4% -10.6% -189.5% -14.9% -125.1% -36.9% -16.2% -74.2% -97.7% -24.1% 1370.9% -994.4% -6371.0% 1.0% -1783.0% 1.0% -3195.7% -523.9% 97.7% 32.6% 32.56%
Operating Margin -52.1% -16.6% -269.2% -21.7% -175.5% -53.0% -23.0% -101.0% -134.5% -69.2% 1929.1% -1362.0% -8491.2% -17044.0% -56117.0% -3830.1% -3963.7% -679.8% 17.3% -24.2% -24.16%
Net Margin -52.1% -16.3% -272.6% -21.6% -173.4% -51.4% -22.0% -96.2% -123.9% -50.8% 1699.1% -1157.2% -6990.6% -14614.3% -49671.0% -3426.6% -3643.9% -632.0% 22.8% -22.6% -22.57%
EBITDA Margin -49.6% -16.3% -264.9% -21.3% -172.6% -52.0% -22.2% -97.6% -129.9% -64.2% 1871.1% -1320.1% -8252.4% -16476.3% -61038.0% -3704.8% -3886.0% -617.9% 7.3% -23.5% -23.49%
FCF Margin -3.3% -4.1% -4.3% -5.3% -34.2% -51.6% -31.4% -44.0% -42.9% -3.5% -3.8% -3.9% -4.3% -6868.1% -3739.8% -6824.4% -5145.8% -1542.1% -1.3% -1.5% -1.47%
OCF Margin -3.1% -3.8% -3.8% -4.5% -28.5% -43.7% -27.7% -41.3% -40.8% -3.3% -3.7% -3.8% -4.2% -6668.9% -3637.4% -6663.3% -5042.1% -1529.1% -1.3% -1.5% -1.47%
ROE 3Y Avg snapshot only -33.45%
ROE 5Y Avg snapshot only -34.66%
ROA 3Y Avg snapshot only -30.21%
ROIC Economic snapshot only -27.00%
Cash ROA snapshot only -22.84%
Cash ROIC snapshot only -1.04%
CROIC snapshot only -1.05%
NOPAT Margin snapshot only -1.61%
Pretax Margin snapshot only -1.82%
R&D / Revenue snapshot only 2.49%
SGA / Revenue snapshot only 54.18%
SBC / Revenue snapshot only 11.41%
Valuation
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
P/E Ratio -14.46 -10.91 -8.31 -6.00 -2.22 -2.48 -6.71 -5.12 -6.22 -5.61 -7.86 -15.01 -10.56 -4.19 -1.87 -1.02 -1.06 -2.33 -3.10 -3.94 -3.638
P/S Ratio 41.27 42.95 32.87 28.24 79.47 131.97 230.67 254.88 303.29 24.46 38.26 76.76 57.39 35326.11 8120.72 7828.40 6287.56 4064.48 5.10 7.18 5.095
P/B Ratio 2.51 2.84 1.86 1.53 0.71 0.82 3.12 2.43 2.99 2.33 2.58 5.10 3.77 1.95 0.59 0.35 0.41 0.96 0.86 1.25 1.296
P/FCF -12.63 -10.51 -7.58 -5.29 -2.32 -2.56 -7.35 -5.79 -7.06 -7.02 -10.09 -19.76 -13.31 -5.14 -2.17 -1.15 -1.22 -2.64 -3.94 -4.87 -4.872
P/OCF
EV/EBITDA -8.50 -6.90 -5.18 -3.21 0.06 -0.28 -4.87 -3.30 -4.35 -3.38 -4.78 -11.12 -7.00 -2.00 0.53 1.08 0.87 -0.39 -0.33 -1.41 -1.408
EV/Revenue 23.53 26.64 20.04 14.84 -2.01 14.73 167.55 165.42 216.85 15.49 25.06 63.38 43.86 19234.29 -2697.42 -9574.68 -5841.86 728.89 0.62 2.86 2.861
EV/EBIT -8.28 -6.75 -5.07 -3.14 0.06 -0.27 -4.76 -3.21 -4.22 -3.24 -4.60 -10.72 -6.76 -1.94 0.53 1.08 0.87 -0.39 -0.33 -1.41 -1.406
EV/FCF -7.20 -6.52 -4.62 -2.78 0.06 -0.29 -5.34 -3.76 -5.05 -4.44 -6.61 -16.32 -10.17 -2.80 0.72 1.40 1.14 -0.47 -0.48 -1.94 -1.941
Earnings Yield -6.9% -9.2% -12.0% -16.7% -45.1% -40.4% -14.9% -19.5% -16.1% -17.8% -12.7% -6.7% -9.5% -23.9% -53.5% -98.0% -94.5% -42.9% -32.2% -25.4% -25.39%
FCF Yield -7.9% -9.5% -13.2% -18.9% -43.1% -39.1% -13.6% -17.3% -14.2% -14.3% -9.9% -5.1% -7.5% -19.4% -46.1% -87.2% -81.8% -37.9% -25.4% -20.5% -20.52%
Price/Tangible Book snapshot only 1.253
Shareholder Yield snapshot only 0.00%
Leverage & Solvency
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Current Ratio 16.88 16.88 15.69 15.69 15.69 15.69 14.02 14.02 14.02 14.02 15.65 15.65 15.65 15.65 14.92 14.92 14.92 14.92 9.39 9.39 9.393
Quick Ratio 16.88 16.88 15.69 15.69 15.69 15.69 14.02 14.02 14.02 14.02 15.65 15.65 15.65 15.65 14.92 14.92 14.92 14.92 9.39 9.39 9.393
Debt/Equity 0.00 0.00 0.05 0.05 0.05 0.05 0.07 0.07 0.07 0.07 0.05 0.05 0.05 0.05 0.05 0.05 0.05 0.05 0.04 0.04 0.042
Net Debt/Equity -1.08 -1.08 -0.72 -0.72 -0.72 -0.72 -0.85 -0.85 -0.85 -0.85 -0.89 -0.89 -0.89 -0.89 -0.78 -0.78 -0.78 -0.78 -0.75 -0.75 -0.754
Debt/Assets 0.00 0.00 0.05 0.05 0.05 0.05 0.06 0.06 0.06 0.06 0.04 0.04 0.04 0.04 0.04 0.04 0.04 0.04 0.04 0.04 0.038
Debt/EBITDA -0.00 -0.00 -0.24 -0.21 -0.16 -0.16 -0.15 -0.15 -0.14 -0.16 -0.14 -0.13 -0.12 -0.09 -0.13 -0.12 -0.11 -0.11 -0.13 -0.12 -0.119
Net Debt/EBITDA 6.40 4.23 3.31 2.90 2.30 2.22 1.83 1.78 1.73 1.96 2.52 2.35 2.16 1.68 2.12 1.97 1.81 1.76 2.39 2.13 2.127
Interest Coverage -228.63 -260.94 -327.70 -339.99
Equity Multiplier 1.12 1.12 1.11 1.11 1.11 1.11 1.13 1.13 1.13 1.13 1.10 1.10 1.10 1.10 1.10 1.10 1.10 1.10 1.12 1.12 1.121
Cash Ratio snapshot only 9.154
Cash to Debt snapshot only 18.804
FCF to Debt snapshot only -6.074
Defensive Interval snapshot only 871.9 days
Efficiency & Turnover
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Asset Turnover 0.05 0.06 0.06 0.05 0.01 0.01 0.01 0.01 0.01 0.07 0.07 0.07 0.07 0.00 0.00 0.00 0.00 0.00 0.15 0.16 0.157
Inventory Turnover
Receivables Turnover 10.50 11.42 23.53 22.51 3.70 2.57 8.37 5.91 6.12 58.87 59.21 58.43 57.77 0.05
Payables Turnover 22.72 31.58 18.73 20.75 22.34 23.29 19.85 20.60 21.38 22.89 28.40 30.00 32.42 25.09 15.57 8.52 12.59 24.55 12.50 12.77 12.766
DSO 35 32 16 16 99 142 44 62 60 6 6 6 6 7515 0 0 0 0 0 0 0.0 days
DIO 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.0 days
DPO 16 12 19 18 16 16 18 18 17 16 13 12 11 15 23 43 29 15 29 29 28.6 days
Cash Conversion Cycle 19 20 -4 -1 82 126 25 44 43 -10 -7 -6 -5 7500 -23 -43 -29 -15 -29 -29 -28.6 days
Fixed Asset Turnover snapshot only 2.673
Cash Velocity snapshot only 0.219
Capital Intensity snapshot only 6.422
Growth (YoY)
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue 19.5% 15.9% -81.8% -88.4% -82.7% -87.2% -19.5% 10.1% 5.6% 8.3% 7.9% -99.9% -99.8% -99.9% -99.8% 6.1% 2301.9% 3835.6% 3835.61%
Net Income -2.5% -1.2% -1.3% -57.5% -50.7% -35.2% -9.5% 8.8% 6.2% 4.8% 1.3% -49.6% -59.5% -68.8% -78.5% -45.8% 12.9% 8.8% 8.81%
EPS -2.4% -82.1% -89.0% -31.4% -25.4% -33.2% 7.7% 30.1% 22.1% 36.8% 31.6% -13.8% -15.7% -49.2% -76.4% -44.3% 18.9% 25.3% 25.32%
FCF -3.3% -1.7% -90.8% -46.9% -25.5% -5.4% -0.9% 24.7% 20.0% 18.2% 11.1% -52.3% -76.1% -97.6% -94.8% -58.5% 20.3% 17.1% 17.14%
EBITDA -2.5% -1.2% -1.3% -59.3% -54.2% -38.6% -13.1% 3.3% -1.0% -5.3% -11.4% -61.9% -73.6% -74.7% -74.1% -39.0% 15.4% 12.0% 11.96%
Op. Income -2.5% -1.2% -1.3% -58.3% -54.3% -39.7% -14.9% 1.1% -2.6% -6.3% -11.7% -60.5% -66.4% -68.2% -67.9% -36.8% 15.1% 11.7% 11.70%
OCF Growth snapshot only 15.53%
Asset Growth snapshot only 1.13%
Equity Growth snapshot only -0.97%
Debt Growth snapshot only -12.98%
Shares Change snapshot only 22.10%
Growth (CAGR)
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue 3Y 1.7% 9.0% -90.0% -87.3% -89.0% -77.3% -60.7% 2.0% 2.4% 2.42%
Revenue 5Y 1.4% 1.44%
EPS 3Y
EPS 5Y
Net Income 3Y
Net Income 5Y
EBITDA 3Y
EBITDA 5Y
Gross Profit 3Y
Gross Profit 5Y
Op. Income 3Y
Op. Income 5Y
FCF 3Y
FCF 5Y
OCF 3Y
OCF 5Y
Assets 3Y 5.6% 5.6% 5.6% 5.6% 16.6% 16.6% 16.6% 16.6% 29.4% 29.4% 29.35%
Assets 5Y 14.5% 14.5% 14.47%
Equity 3Y 6.3% 6.3% 6.3% 6.3% 17.0% 17.0% 17.0% 17.0% 29.8% 29.8% 29.78%
Book Value 3Y -6.4% -13.4% -16.6% -16.4% -7.1% -2.6% -2.6% -2.6% 7.0% 1.7% 1.67%
Dividend 3Y
Growth Quality
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue Stability 0.04 0.00 0.78 0.06 0.36 0.31 0.04 0.13 0.20 0.17 0.02 0.11 0.46 0.44 0.444
Earnings Stability 0.99 0.98 0.86 0.53 0.82 0.81 0.70 0.81 0.91 0.89 0.83 0.87 0.84 0.88 0.878
Margin Stability 0.19 0.15 0.00 0.00 0.03 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.000
Rev. Growth Consistency 0.00 0.00 0.50 0.50 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.500
Earn. Growth Consistency 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.500
FCF Positive Streak 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Earnings Persistence 0.50 0.86 0.96 0.96 0.98 0.98 0.99 0.80 0.50 0.50 0.50 0.82 0.95 0.96 0.965
Earnings Smoothness
ROE Trend -0.31 -0.28 -0.24 -0.12 0.02 0.03 0.04 -0.09 0.08 0.06 0.04 0.03 0.04 0.02 0.024
Gross Margin Trend -23.36 -23.66 16.78 9.84 15.82 26.33 -5023.15 -1647.37 -1441.41 -1485.46 1716.29 832.47 732.77 732.774
FCF Margin Trend -24.73 -24.18 24.37 14.08 20.80 34.28 -6840.56 -3722.16 -6800.48 -5122.22 1893.71 1870.48 3412.69 3412.686
Sustainable Growth Rate
Internal Growth Rate
Cash Flow Quality
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
OCF/Net Income 1.10 0.97 0.97 0.95 0.80 0.82 0.81 0.83 0.84 0.76 0.75 0.74 0.77 0.79 0.84 0.87 0.85 0.88 0.78 0.80 0.805
FCF/OCF 1.04 1.07 1.13 1.19 1.20 1.18 1.13 1.07 1.05 1.05 1.04 1.03 1.02 1.03 1.03 1.02 1.02 1.01 1.01 1.00 1.005
FCF/Net Income snapshot only 0.808
CapEx/Revenue 12.1% 26.6% 50.5% 86.2% 5.7% 7.9% 3.7% 2.8% 2.1% 15.1% 13.4% 12.1% 10.0% 199.2% 102.3% 161.2% 103.8% 13.0% 1.5% 0.7% 0.69%
CapEx/Depreciation snapshot only 2.013
Accruals Ratio 0.02 -0.01 -0.01 -0.01 -0.06 -0.06 -0.07 -0.06 -0.06 -0.07 -0.08 -0.09 -0.08 -0.10 -0.06 -0.05 -0.07 -0.06 -0.06 -0.06 -0.056
Sloan Accruals snapshot only -0.066
Cash Flow Adequacy snapshot only -213.612
Dividends & Buybacks
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Dividend Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Dividend/Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Payout Ratio
FCF Payout Ratio
Total Payout Ratio
Div. Increase Streak
Chowder Number
Buyback Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Net Buyback Yield -31.7% -28.3% -0.2% -0.5% -1.1% -0.4% -0.4% -2.2% -20.5% -28.0% -18.7% -28.9% -29.3% -55.2% -1.1% -9.0% -0.7% -0.3% -26.0% -19.6% -19.62%
Total Shareholder Return -31.7% -28.3% -0.2% -0.5% -1.1% -0.4% -0.4% -2.2% -20.5% -28.0% -18.7% -28.9% -29.3% -55.2% -1.1% -9.0% -0.7% -0.3% -26.0% -19.6% -19.62%
DuPont Factors
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Tax Burden (NI/EBT) 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.000
Interest Burden (EBT/EBIT) 1.00 1.00 1.00 1.00 1.00 0.99 0.98 0.97 0.95 0.91 0.89 0.86 0.84 0.85 0.86 0.87 0.89 0.93 0.88 0.90 0.896
EBIT Margin -2.84 -3.95 -3.95 -4.72 -36.01 -53.76 -35.18 -51.54 -51.43 -4.77 -5.45 -5.91 -6.49 -9904.47 -5076.78 -8840.26 -6676.55 -1883.92 -1.87 -2.03 -2.035
Asset Turnover 0.05 0.06 0.06 0.05 0.01 0.01 0.01 0.01 0.01 0.07 0.07 0.07 0.07 0.00 0.00 0.00 0.00 0.00 0.15 0.16 0.157
Equity Multiplier 1.12 1.12 1.12 1.12 1.12 1.12 1.12 1.12 1.12 1.12 1.12 1.12 1.12 1.12 1.10 1.10 1.10 1.10 1.11 1.11 1.109
Per Share
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
EPS (Diluted TTM) $-1.67 $-2.47 $-2.64 $-2.52 $-3.15 $-3.25 $-3.31 $-3.36 $-2.91 $-2.27 $-2.58 $-2.12 $-1.99 $-2.58 $-2.98 $-3.17 $-3.51 $-3.73 $-2.42 $-2.36 $-2.36
Book Value/Share $9.59 $9.49 $11.81 $9.90 $9.87 $9.85 $7.12 $7.07 $6.03 $5.47 $7.87 $6.25 $5.57 $5.54 $9.47 $9.16 $9.13 $9.10 $8.73 $7.43 $6.64
Tangible Book/Share $9.59 $9.49 $11.81 $9.90 $9.87 $9.85 $7.12 $7.07 $6.03 $5.47 $7.87 $6.25 $5.57 $5.54 $9.47 $9.16 $9.13 $9.10 $8.73 $7.43 $7.43
Revenue/Share $0.58 $0.63 $0.67 $0.54 $0.09 $0.06 $0.10 $0.07 $0.06 $0.52 $0.53 $0.42 $0.37 $0.00 $0.00 $0.00 $0.00 $0.00 $1.47 $1.30 $1.30
FCF/Share $-1.91 $-2.57 $-2.90 $-2.86 $-3.01 $-3.14 $-3.02 $-2.97 $-2.56 $-1.81 $-2.01 $-1.61 $-1.58 $-2.10 $-2.57 $-2.82 $-3.04 $-3.30 $-1.90 $-1.91 $-1.91
OCF/Share $-1.84 $-2.40 $-2.56 $-2.40 $-2.51 $-2.66 $-2.67 $-2.78 $-2.43 $-1.74 $-1.94 $-1.56 $-1.54 $-2.04 $-2.49 $-2.75 $-2.98 $-3.27 $-1.88 $-1.90 $-1.90
Cash/Share $10.35 $10.24 $9.17 $7.69 $7.67 $7.65 $6.57 $6.53 $5.57 $5.05 $7.37 $5.85 $5.21 $5.19 $7.88 $7.62 $7.60 $7.57 $6.95 $5.92 $5.74
EBITDA/Share $-1.62 $-2.42 $-2.58 $-2.48 $-3.11 $-3.22 $-3.31 $-3.38 $-2.97 $-2.39 $-2.78 $-2.37 $-2.29 $-2.94 $-3.50 $-3.65 $-3.94 $-4.04 $-2.75 $-2.63 $-2.63
Debt/Share $0.00 $0.00 $0.61 $0.51 $0.51 $0.51 $0.50 $0.49 $0.42 $0.38 $0.37 $0.30 $0.27 $0.26 $0.46 $0.44 $0.44 $0.44 $0.37 $0.31 $0.31
Net Debt/Share $-10.35 $-10.24 $-8.56 $-7.18 $-7.16 $-7.14 $-6.08 $-6.03 $-5.15 $-4.67 $-6.99 $-5.55 $-4.95 $-4.92 $-7.42 $-7.18 $-7.16 $-7.13 $-6.58 $-5.60 $-5.60
Academic Models
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Altman Z-Score 4.350
Altman Z-Prime snapshot only 8.923
Piotroski F-Score 1 2 3 3 2 2 2 1 2 3 5 5 5 4 2 3 3 3 5 4 4
Beneish M-Score 32.68 16.54 32.22 13.76 50.24 5.71 111.77 -6.99 -14.60 -1613.17 -527.42 1.20 24.32 74932.61 191.94 191.938
Ohlson O-Score snapshot only -4.983
ROIC (Greenblatt) snapshot only -44.65%
Net-Net WC snapshot only $5.17
EVA snapshot only $-154283540.00
Credit
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Credit Rating snapshot only A+
Credit Score 89.00 89.00 61.06 61.83 52.68 60.45 76.78 76.20 76.41 76.48 76.71 76.44 76.56 76.30 59.75 50.10 49.83 73.61 64.25 75.61 75.608
Credit Grade snapshot only 5
Credit Trend snapshot only 25.506
Implied Spread (bps) snapshot only 125.000
Industry Credit Rank snapshot only 76
Sector Credit Rank snapshot only 70

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms